Related Experiment Video
Updated: Apr 29, 2026

05:59
Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
Published on: August 30, 2019
11.8K
[Resecting hematogenous metastases: reasons against]
1Urologische Klinik und Poliklinik, Universitätsmedizin, Johannes Gutenberg Universität Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland, frederik.roos@unimedizin-mainz.de.
Der Urologe. Ausg. A
|May 15, 2014
Summary
Resecting metastases from urological cancers can improve survival, but patient selection is crucial. Current evidence does not support resecting prostate cancer metastases.
Area of Science:
- Urology
- Surgical Oncology
- Medical Oncology

